The signal transducers and activators of transcription (STAT) proteins are a group of transcriptional factors. Among them, STAT5 initiates a pro-survival signaling cascade. So far, little has been known about the role of STAT5 in cerebral ischemia and reperfusion. This study examines the phosphorylation status of STAT5 in hippocampal CA1 in the early stage after transient global cerebral ischemia in rats. Our data show that the phosphorylation of STAT5 was increased in hippocampal CA1 at 1h and 3h ischemia. Taking advantage of the neuroprotective effect of erythropoietin (EPO) in CA1, we further demonstrated that the administration of EPO enhanced the phosphorylation of STAT5, with SATA5a being phosphorylated earlier. The enhanced phosphorylation of STAT5 in the EPO-treated group was accompanied by the upregulation of STAT5 downstream gene products, Bcl-xL and XIAP. Consequently, ischemic CA1 neuronal damage was attenuated by the administration of EPO. Both the enhancement of STAT5 phosphorylation and the neuroprotection rendered by EPO were blocked by Tyrphostin, a selective inhibitor for Janus kinase 2, which is an upstream kinase of STAT5. These findings suggest an association between the activation of STAT5 and CA1 neuronal survival after cerebral ischemia.
Introduction
The signal transducers and activators of transcription (STAT) proteins are a group of transcriptional factors. So far, seven STAT members have been described: STAT1, 2, 3, 4, 5a, 5b and 6. Each STAT protein has three major structures: a DNA binding domain, an src-homology (SH2) domain for dimerization and a conserved tyrosine residue that can be phosphorylated by Janus protein kinases (Battle and Frank, 2002; Paukku and Silvennoinen, 2004) . This group of transcription factors responds rapidly to stimuli because once activated through phosphorylation, they dimerize and translocate into the nucleus without the involvement of second messengers (Aaronson and Horvath, 2002) . The classical function of STATs is to mediate the signaling pathways of cytokines and growth factors. Some of the STAT members also are reported to be able to regulate the processes of apoptosis (Battle and Frank, 2002) . Whereas other STATs can mediate pro-apoptotic or antiapoptotic signals depending on the conditions of cellular stimulation, STAT5 only demonstrates a pro-survival signal (DebierreGrockiego, 2004) .
STAT5 is phosphorylated at tyrosine 694 by Janus kinase 2 (JAK2) and thus gains the ability of translocation to the nucleus and the activity of binding to specific DNA sequences in the promoters of responsive genes to enhance gene transcription (Battle and Frank, 2002; Paukku and Silvennoinen, 2004) . STAT5 was originally recognized as a transcription factor that regulates the β-casein gene in response to prolactin, but STAT5 is also activated by several other cytokines and growth factors, such as erythropoietin (EPO), growth hormone and interleukins (Gobert et al., 1996; Battle and Frank, 2002; Debierre-Grockiego, 2004; Paukku and Silvennoinen, 2004) . STAT5 is reported to play an important anti-apoptotic role in heart induced by cardiac ischemia (Yamaura et al., 2003) , in endothelial cells induced by hypoxia (Dudley et al., 2005) , and in the survival of hematopoietic cells (Battle and Frank, 2002; Debierre-Grockiego, 2004 ) and neuroblastoma SH-SY5Y cells (Um and Lodish, 2006) . Downstream products of STA5 related to the regulation of apoptosis include Bcl-xL (Socolovsky et al., 1999) and the X-linked inhibitor of apoptosis protein (XIAP) (Mohapatra et al., 2003) . Both Bcl-xL and XIAP demonstrate antiapoptotic effects in ischemic brain (Zhang et al., 2004) .
